Header Logo

Connection

WILLEM OVERWIJK to Abatacept

Back to Details
This is a "connection" page, showing publications WILLEM OVERWIJK has written about Abatacept.
WILLEM OVERWIJK
Connection Strength
0.012
Abatacept
  1. Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy. J Exp Med. 2001 Aug 20; 194(4):481-9.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.